Skip to main content

IDENTIFICACION DE ESTRATEGIAS DE INTERVENCION BASADAS EN EL MICROBIOMA INTESTINAL PARA REDUCIR EL RIESGO DE DESARROLLAR OBESIDAD, DEPRESION Y SUS COMORBILIDADES

PRE2018-083895

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Formación
Call Contratos Predoctorales
Call year 2018
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Gut microbiome signatures associated with depression and obesity

  • Mora-Martínez, Carlos
  • Molina-Mendoza, Gara
  • Cenit, Maria Carmen
  • Medina-Rodríguez, Eva M.
  • Larroya-Garcia, Ana
  • Sánchez-Carro, Yolanda
  • González-Blanco, Leticia
  • Bobes, Julio
  • López-García, Pilar
  • Zandio-Zorrilla, Mercedes
  • Lahortiga-Ramos, Francisca
  • Gili, Margalida
  • García-Toro, Mauro
  • Barcelo, Bernardino
  • Ibarra, Olga
  • Sanz, Yolanda
[EN] Depression and obesity are highly comorbid and likely involve common risk factors and pathophysiological mechanisms, which could crosslink to gut microbiome dysfunction. Here, we performed a case-control study with a total of 105 subjects, 43 with major depressive disorder (MDD) and 62 non-depressed controls free from psychiatric comorbidities, to identify gut microbiome signatures associated with MDD and dissect its relation to body mass index (BMI) and lifestyle (diet and exercise). We performed shotgun metagenomics, followed by taxonomic and functional annotations. Using different machine learning methods, we were able to classify subjects into depressed and non-depressed controls with a balanced accuracy of 0.90 and into depressed or non-depressed and normal weight or overweight with a balanced accuracy of 0.78 based solely on taxonomic profiles. We identify novel bacterial taxa associated with depression, including reductions in Butyrivibrio hungatei and Anaerocolumna sedimenticola, and also replicate previously reported associations, such as decreased Faecalibacterium prausnitzii in patients with MDD. Functional annotation of metagenomes shows differences in pathways linked to the synthesis of fundamental nutrients, which have been associated with diet, as well as inflammation. Strikingly, we found an increase in tryptophan degradation and a decrease in queuosine synthesis pathways, both of which are directly related to a decrease in monoaminergic neurotransmitter availability. Additionally, our functional analysis shows that most of the functions that are more abundant in controls than in depressed subjects are encoded by F. prausnitzii. These findings reveal distinct microbial and functional signatures associated with depression, including taxa and pathways linked to neurotransmitter metabolism and independent of other covariates. This suggests that gut microbiome profiling could support diagnosis and the development of gut-directed depression treatments., Metagenomics; Depression; Major depressive disorder; Body mass index; Faecalibacterium prausnitzii; Overweight; Machine learning
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Gut microbiome signatures associated with depression and obesity

  • Mora-Martínez, Carlos
  • Molina-Mendoza, Gara V.
  • Cénit, M. Carmen
  • Medina Rodríguez, Eva M.
  • Larroya, Ana
  • Sánchez-Carro, Yolanda
  • González-Blanco, Leticia
  • Bobes, Julio
  • López García, Pilar
  • Zandio-Zorrilla, Mercedes
  • Lahortiga-Ramos, Francisca
  • Gili, Margalida
  • Garcia-Toro, Mauro
  • Barcelo, Bernardino
  • Ibarra, Olga
  • Sanz, Yolanda
Depression and obesity are highly comorbid and likely involve common risk factors and pathophysiological mechanisms, which could crosslink to gut microbiome dysfunction. Here, we performed a case-control study with a total of 105 subjects, 43 with major depressive disorder (MDD) and 62 non-depressed controls free from psychiatric comorbidities, to identify gut microbiome signatures associated with MDD and dissect its relation to body mass index (BMI) and lifestyle (diet and exercise). We performed shotgun metagenomics, followed by taxonomic and functional annotations. Using different machine learning methods, we were able to classify subjects into depressed and non-depressed controls with a balanced accuracy of 0.90 and into depressed or non-depressed and normal weight or overweight with a balanced accuracy of 0.78 based solely on taxonomic profiles. We identify novel bacterial taxa associated with depression, including reductions in Butyrivibrio hungatei and Anaerocolumna sedimenticola, and also replicate previously reported associations, such as decreased Faecalibacterium prausnitzii in patients with MDD. Functional annotation of metagenomes shows differences in pathways linked to the synthesis of fundamental nutrients, which have been associated with diet, as well as inflammation. Strikingly, we found an increase in tryptophan degradation and a decrease in queuosine synthesis pathways, both of which are directly related to a decrease in monoaminergic neurotransmitter availability. Additionally, our functional analysis shows that most of the functions that are more abundant in controls than in depressed subjects are encoded by F. prausnitzii. These findings reveal distinct microbial and functional signatures associated with depression, including taxa and pathways linked to neurotransmitter metabolism and independent of other covariates. This suggests that gut microbiome profiling could support diagnosis and the development of gut-directed depression treatments., This study was supported by the European Union’s Horizon 2020 research and innovation programme (EarlyCause, grant no 848158), by the European Commission—NextGeneration EU funds through CSIC Interdisciplinary Thematic Platform Neuroaging+, and by a grant from the Spanish Ministry of Science, Innovation and Universities (MCIU/AEI), to IATA-CSIC as an Accredited Research Centre of Excellence (CEX2021-001189S/MCIN/AEI/10.13039/501100011033). The FPI contract to G.M.-M. is supported by the Spanish Ministry of Science and Innovation (PRE2018-083895). E.M.M.-R. is supported by a Miguel Servet contract from the Institute of Health Carlos III (CP22/00031), the Spanish Ministry of Science, Innovation and Universities (MCIU/AEI) (PID2022-142106OA-I00), and co-funded by the European Union., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001189S)., Peer reviewed